Archive
Cancer care startup Thyme Care has raised $125 million in Series E funding at a valuation above $2 billion. Led by Morgan Health, the round coincides with the creation of a new parent company, Thyme Companies, to expand into biosimilar adoption and clinical trial navigation.
The biotechnology company plans to move nonviral treatments for Duchenne muscular dystrophy and polycystic kidney disease toward clinical testing.
The vertical software company is connecting agency data with AI workflows for policy checks, proposals and other document-heavy tasks.
The autonomous drone maker reached a $4.4 billion valuation as it increases production for defense, public safety and infrastructure customers.
The Santa Clara startup is combining navigation, communications and computing functions in silicon intended for drones and robots.
The Mountain View robotics company reached a $1.15 billion valuation with a plan to begin real household deployments in the fall.
